Map roles, branches and approval responsibilities
Confirmed with your team before production reliance.
CoreCare Care
Domiciliary care management software
A practical way to connect care plans, risk, rotas, visits and manager oversight without assuming every provider works identically.
Guided evaluation Representative workflows are available to evaluate now. This status does not mean unrestricted production approval; care governance, migration and readiness must be agreed before live use.
Who this is for
Start with the operating problem.
For UK domiciliary and community care providers reviewing how staff, visits, care information and exceptions are coordinated.
Common warning signs
- Care information is spread between paper, spreadsheets and messages
- Coordinators see changes too late
- Managers spend time assembling evidence instead of reviewing exceptions
Evaluate representative care, rota and visit workflows
Confirmed with your team before production reliance.
Agree governance, migration and readiness before using real care data
Confirmed with your team before production reliance.
Practical questions
Know what must be confirmed.
Every organisation is different. These answers describe the current public scope, not a hidden promise.
View full product detailCan we use real service-user information in the trial?+
The initial evaluation uses representative information. Real data is introduced only after security, governance and migration arrangements are agreed.
Is this automatically suitable for every CQC-regulated provider?+
No. The provider remains responsible for regulatory and clinical governance and must approve the production scope.